Bibliography
- Amaral PP, Dinger ME, Mercer TR, et al. The eukaryotic genome as an RNA machine. Science 2008;319:1787-9
- Tseng HH, Weinberg Z, Gore J, et al. Finding non-coding RNAs through genome-scale clustering. J Bioinform Comput Biol 2009;7(2):373-88
- Kapranov P, Ozsolak F, Milos PM. Profiling of short RNAs using Helicos single-molecule sequencing. Methods Mol Biol 2012;822:219-32
- Volinia S, Galasso M, Costinean S, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010;20(5):589-99
- Spizzo R, Nicoloso MS, Croce CM, Calin GA. SnapShot: microRNAs in cancer. Cell 2009;137(3):586-586.e1
- Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 2009;9(4):293-302
- Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136(2):215-33
- Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007;67(13):6092-9
- Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 2013;3(10):1113-21
- Bak RO, Mikkelsen JG. miRNA sponges: soaking up miRNAs for regulation of gene expression. Wiley Interdiscip Rev RNA 2014;5(3):317-33
- Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007;4(9):721-6
- Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011;146:353-8
- Bosia C, Pagnani A, Zecchina R. Modelling competing endogenous RNA networks. PLoS One 2013;8(6):e66609
- Sumazin P, Yang X, Chiu HS, et al. An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 2011;147(2):370-81
- Figliuzzi M, Marinari E, De Martino A. MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys J 2013;104:1203-13
- Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol 2010;20(19):R858-61
- Almeida MI, Reis RM, Calin GA. Decoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther 2012;12(9):1153-9
- Nishimura M, Jung EJ, Shah MY, et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment. Cancer Discov 2013;3(11):1302-15
- Landen CN, Kinch MS, Sood AK. EphA2 as a target for ovarian cancer therapy. Expert OpinTher Targets 2005;9(6):1179-87
- Balkhi MY, Iwenofu OH, Bakkar N, et al. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR. Sci Signal 2013;6(286):ra63
- Ala U, Karreth FA, Bosia C, et al. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc Natl Acad Sci USA 2013;110(18):7154-9
- Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014;505(7483):344-52
- Karreth FA, Tay Y, Perna D, et al. In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011;147(2):382-95
- Su X, Xing J, Wang Z, et al. microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. Chin J Cancer Res 2013;25(2):235-9
- Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012;482(7385):347-55
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144(5):646-74
- Seo H, Kim W, Lee J, Youn B. Network-based approaches for anticancer therapy (Review). Int J Oncol 2013;43(6):1737-44
- Cesana M, Daley GQ. Deciphering the rules of ceRNAnetworks. Proc Natl Acad Sci USA 2013;110(18):7112-13
- Martinez NJ, Walhout AJ. The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays 2009;31(4):435-45
- Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013;12(11):847-65
- Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010;38:5366-83
- Calin GA, Vasilescu C, Negrini M, Barbanti-Brodano G. Genetic chaos and antichaos in human cancers. Med Hypotheses 2003;60(2):258-62
- Denzler R, Agarwal V, Stefano J, et al.Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol Cell 2014, pii: S1097-2765(14)00278-0